BIIB078

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	2

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04288856 (ClinicalTrials.gov)	April 28, 2020	26/2/2020	Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BII ...	An Extension Study to Assess the Long-Term Safety, Tolerability, Pharmacokinetics, and Effect on Dis ...	Amyotrophic Lateral Sclerosis	Drug: BIIB078	Biogen	NULL	Terminated	18 Years	N/A	All	75	Phase 1	United States;Canada;Netherlands;Switzerland;United Kingdom
2	NCT03626012 (ClinicalTrials.gov)	September 10, 2018	7/8/2018	A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078in Adults With C9ORF72-As ...	A Phase 1 Multiple-Ascending-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ...	Amyotrophic Lateral Sclerosis	Drug: BIIB078;Drug: Placebo	Biogen	NULL	Completed	18 Years	N/A	All	106	Phase 1	United States;Canada;Ireland;Netherlands;Switzerland;United Kingdom

First Previous1Next Last